Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;132(9):1829-1834.
doi: 10.1002/lary.30122. Epub 2022 Mar 30.

Depression Symptoms and Olfactory-related Quality of Life

David T Liu  1 , Bernhard Prem  1 , Gunjan Sharma  1 , Julia Kaiser  1 , Gerold Besser  1 , Christian A Mueller  1
Affiliations

Depression Symptoms and Olfactory-related Quality of Life

David T Liu et al. Laryngoscope. 2022 Sep.

Abstract

Objectives: Patients with olfactory dysfunction (OD) frequently report symptoms of depression. The objective of this study was to determine how clinical characteristics and olfactory-related quality of life (QoL) measures associate with the likelihood for major depressive disorders (MDDs).

Methods: A total of 192 OD patients were included. Olfactory function was measured using all three subtests of the Sniffn' Sticks test. Olfactory-related quality of life (QoL) was evaluated using the Questionnaires of Olfactory Dysfunction (QOD)-negative (NS) and -positive statement (PS). The likelihood for MDD was assessed using the Patients Health Questionnaire-2 (PHQ-2). Demographics and disease-specific variables (etiology and duration of OD) were collected. Univariate and multivariable analyses were used to associate disease-specific variables and the QOD with the outcome of the PHQ-2. Additionally, the predictive ability of the QOD-NS to predict depressive symptoms was calculated.

Results: In univariate analysis, COVID-19 related smell loss, the QOD-NS, and the QOD-PS were significantly associated with the PHQ-2. In multivariable analyses adjusting for QoL measures, the QOD-NS (ß = 0.532, p < 0.001) and sinonasal OD (compared with postinfectious OD) were significantly associated with the PHQ-2 (ß = 0.146, p = 0.047). When omitting QoL measures from multivariable analyses, only COVID-19 related OD (compared with postinfectious OD) was significantly associated with the PHQ-2 (ß = 0.287, p = 0.009). A QOD-NS score > 20.5 had 70.13% sensitivity and 76.32% specificity for detecting symptoms of depression.

Conclusion: Our results suggest that COVID-19 related OD might be associated with a higher likelihood for MDD. Furthermore, we showed that the QOD-NS score might be helpful to predict symptoms of depression in OD patients.

Level of evidence: 4 Laryngoscope, 132:1829-1834, 2022.

Keywords: PROM; anosmia; depression; hyposmia; olfactory dysfunction; quality of life; smell loss.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Figures

Fig. 1
Fig. 1
Scattergram (mean ± SD) of the PHQ‐2 score by different reasons for smell loss. Groups were compared by the ANOVA test with post hoc Tukey's test. *p < 0.05. [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]
Fig. 2
Fig. 2
Receiver operating characteristic curve for the QOD‐NS score as an indicator to score ≥2 on the PHQ‐2. The cutoff of >20.5 (red point) maximizes the sum of sensitivity (70.13%) and specificity (76.32%). [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]
See this image and copyright information in PMC

References

    1. Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life‐an updated review. Chem Senses. 2014;39(3):185‐194. - PubMed
    1. Liu DT, Prem B, Besser G, Renner B, Mueller CA. Olfactory‐related quality of life adjustments in smell loss during the Coronavirus‐19 pandemic. Am J Rhinol Allergy. 2021;36(2):253‐260. - PubMed
    1. Lechien JR, Chiesa‐Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild‐to‐moderate forms of the coronavirus disease (COVID‐19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251‐2261. - PMC - PubMed
    1. Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54(26):1‐30. - PubMed
    1. Kohli P, Soler ZM, Nguyen SA, Muus JS, Schlosser RJ. The association between olfaction and depression: a systematic review. Chem Senses. 2016;41(6):479‐486. - PMC - PubMed

MeSH terms